Pulmonx Corp [LUNG] stock prices are up 32.23% to $8.78 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The LUNG shares have gain 25.25% over the last week, with a monthly amount glided 41.84%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Pulmonx Corp [NASDAQ: LUNG] stock has seen the most recent analyst activity on December 11, 2024, when Citigroup downgraded its rating to a Neutral and also revised its price target to $7.50 from $17. Previously, Lake Street started tracking the stock with Buy rating on June 04, 2024, and set its price target to $12. On February 23, 2024, downgrade downgraded it’s rating to Equal Weight and revised its price target to $14 on the stock. Craig Hallum started tracking the stock assigning a Buy rating and suggested a price target of $18 on September 05, 2023. Wells Fargo upgraded its rating to a Overweight and raised its price target to $15 on February 27, 2023. BofA Securities downgraded its rating to Underperform for this stock on January 03, 2023, but kept the price target unchanged to $8. In a note dated December 12, 2022, Citigroup upgraded an Buy rating on this stock and revised its target price from $14 to $10.
The stock price of Pulmonx Corp [LUNG] has been fluctuating between $5.46 and $14.60 over the past year. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Pulmonx Corp [NASDAQ: LUNG] shares were valued at $8.78 at the most recent close of the market. An investor can expect a potential return of 13.9% based on the average LUNG price forecast.
Analyzing the LUNG fundamentals
The Pulmonx Corp [NASDAQ:LUNG] reported sales of 83.79M for trailing twelve months, representing a surge of 23.28%. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at -0.71%, Pretax Profit Margin comes in at -0.71%, and Net Profit Margin reading is -0.72%. To continue investigating profitability, this company’s Return on Assets is posted at -0.34, Equity is -0.54 and Total Capital is -0.38. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.59.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.80 points at the first support level, and at 6.81 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.57, and for the 2nd resistance point, it is at 10.35.
Ratios To Look Out For
It’s worth pointing out that Pulmonx Corp [NASDAQ:LUNG]’s Current Ratio is 5.58. In addition, the Quick Ratio stands at 4.88 and the Cash Ratio stands at 3.46. Considering the valuation of this stock, the price to sales ratio is 4.14, the price to book ratio is 3.69.
Transactions by insiders
Recent insider trading involved GLENDON FRENCH, Officer, that happened on Feb 20 ’25 when 55453.0 shares were purchased. Director, French Glendon E. III completed a deal on Jan 16 ’25 to sell 2326.0 shares. Meanwhile, Director French Glendon E. III sold 2221.0 shares on Jan 17 ’25.
